Heart valvular disease in patients with Parkinson's disease treated with high-dose pergolide

被引：101

作者：

Van Camp, G

Flamez, A

Cosyns, B

Goldstein, J

Perdaens, C

Schoors, D

机构：

[1] Free Univ Brussels, Akad Ziekenhuis, Dept Cardiol, B-1090 Brussels, Belgium

[2] Free Univ Brussels, Dept Neurol, B-1090 Brussels, Belgium

[3] Free Univ Brussels, Dept Cardiac Surg, B-1090 Brussels, Belgium

[4] Free Univ Brussels, Dept Pathol, B-1090 Brussels, Belgium

来源：

NEUROLOGY | 2003年 / 61卷 / 06期

关键词：

D O I：

10.1212/01.WNL.0000083985.00343.F2

中图分类号：

R74 [神经病学与精神病学];

学科分类号：

摘要：

The authors report the clinical, echocardiographic, and pathologic findings in two patients treated with more than 5 mg of pergolide daily who developed symptomatic severe heart failure due to restrictive valvular disease. They also describe the echocardiographic data of another eight patients taking similar doses of pergolide presenting no clinical signs of heart failure. The findings suggest a possible role of high doses of pergolide in inducing restrictive valvular disease.

引用

收藏

页码：859 / 861

页数：3

相关论文

共 11 条

[1] CARDIAC MURMURS AND ENDOCARDIAL FIBROSIS ASSOCIATED WITH METHYSERGIDE THERAPY [J].

BANA, DS ;

MACNEAL, PS ;

LECOMPTE, PM ;

SHAH, Y ;

GRAHAM, JR .

AMERICAN HEART JOURNAL, 1974, 88 (05) :640-655

[2] Pergolide in the treatment of patients with early and advanced Parkinson's disease [J].

Bonuccelli, U ;

Colzi, A ;

Del Dotto, P .

CLINICAL NEUROPHARMACOLOGY, 2002, 25 (01) :1-10

[3] Valvular heart disease associated with fenfluramine-phentermine [J].

Connolly, HM ;

Crary, JL ;

McGoon, MD ;

Hensrud, DD ;

Edwards, BS ;

Edwards, WD ;

Schaff, HV .

NEW ENGLAND JOURNAL OF MEDICINE, 1997, 337 (09) :581-588

[4] High-dose pergolide monotherapy in the treatment of severe levodopa-induced dyskinesias [J].

Facca, A ;

SanchezRamos, J .

MOVEMENT DISORDERS, 1996, 11 (03) :327-329

[5] DEVELOPMENT OF HEART VALVE LESIONS DURING METHYSERGIDE THERAPY [J].

MISCH, KA .

BRITISH MEDICAL JOURNAL, 1974, 2 (5915) :365-366

[6] VaIvular heart disease in patients taking pergolide [J].

Pritchett, AM ;

Morrison, JF ;

Edwards, WD ;

Schaff, HV ;

Connolly, HM ;

Espinosa, RE .

MAYO CLINIC PROCEEDINGS, 2002, 77 (12) :1280-1286

[7] Improvement of motor fluctuations in patients with Parkinson's disease following treatment with high doses of pergolide and cessation of levodopa [J].

Schwarz, J ;

Scheidtmann, K ;

Trenkwalder, C .

EUROPEAN NEUROLOGY, 1997, 37 (04) :236-238

[8] Appetite suppressants and valvular heart disease [J].

Seghatol, FF ;

Rigolin, VH .

CURRENT OPINION IN CARDIOLOGY, 2002, 17 (05) :486-492

[9]

Serratrice Jacques, 2002, Cardiol Rev, V10, P334, DOI 10.1097/00045415-200211000-00005

[10]

Winkelmann J, 2000, MOVEMENT DISORD, V15, P752, DOI 10.1002/1531-8257(200007)15:4<752::AID-MDS1029>3.0.CO